Literature DB >> 25543888

GATA5 loss-of-function mutation in familial dilated cardiomyopathy.

Xian-Ling Zhang1, Neng Dai1, Kai Tang1, Yan-Qing Chen2, Wei Chen1, Juan Wang3, Cui-Mei Zhao3, Fang Yuan4, Xing-Biao Qiu4, Xin-Kai Qu4, Yi-Qing Yang4, Ya-Wei Xu1.   

Abstract

Dilated cardiomyopathy (DCM), the most common form of primary myocardial disease, is an important cause of sudden cardiac death and heart failure and is the leading indication for heart transplantation in children and adults worldwide. Recent studies have revealed a strong genetic basis for idiopathic DCM, with many distinct genes causally implicated. Nevertheless, DCM is a genetically heterogeneous disorder and the genetic determinants underlying DCM in a substantial proportion of patients remain unclear. In this study, the whole coding exons and flanking introns of the GATA binding protein 5 (GATA5) gene, which codes for a zinc-finger transcription factor essential for cardiovascular development and structural remodeling, were sequenced in 130 unrelated patients with idiopathic DCM. The available relatives of the index patient carrying an identified mutation and 200 unrelated ethnically matched healthy individuals used as the controls were genotyped for GATA5. The functional characteristics of the mutant GATA5 were analyzed in contrast to its wild-type counterpart by using a dual-luciferase reporter assay system. As a result, a novel heterozygous GATA5 mutation, p.G240D, was identified in a family with DCM inherited in an autosomal dominant pattern, which co-segregated with DCM in the family with complete penetrance. The missense mutation was absent in 400 reference chromosomes and the altered amino acid was completely conserved evolutionarily across species. Functional analyses revealed that the GATA5 mutant was associated with significantly diminished transcriptional activity. This study firstly links GATA5 mutation to DCM, which provides novel insight into the molecular mechanisms of DCM, suggesting a potential molecular target for the prenatal prophylaxis and allele-specific treatment of DCM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25543888     DOI: 10.3892/ijmm.2014.2050

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

1.  Identification and Functional Characterization of an ISL1 Mutation Predisposing to Dilated Cardiomyopathy.

Authors:  Ying-Jia Xu; Zhang-Sheng Wang; Chen-Xi Yang; Ruo-Min Di; Qi Qiao; Xiu-Mei Li; Jia-Ning Gu; Xiao-Juan Guo; Yi-Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2018-12-10       Impact factor: 4.132

2.  Compound heterozygous GATA5 mutations in a girl with hydrops fetalis, congenital heart defects and genital anomalies.

Authors:  Maja Hempel; Teresa Casar Tena; Thilo Diehl; Martina S Burczyk; Tim M Strom; Christian Kubisch; Melanie Philipp; Davor Lessel
Journal:  Hum Genet       Date:  2017-02-08       Impact factor: 4.132

3.  A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.

Authors:  Matthew J Winter; Yosuke Ono; Jonathan S Ball; Anna Walentinsson; Erik Michaelsson; Anna Tochwin; Steffen Scholpp; Charles R Tyler; Steve Rees; Malcolm J Hetheridge; Mohammad Bohlooly-Y
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

4.  Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension.

Authors:  Shengxin Tang; Yue Liu; Bin Liu
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

5.  Importance of clitellar tissue in the regeneration ability of earthworm Eudrilus eugeniae.

Authors:  Sayan Paul; Subburathinam Balakrishnan; Arun Arumugaperumal; Saranya Lathakumari; Sandhya Soman Syamala; Vijithkumar Vijayan; Selvan Christyraj Jackson Durairaj; Vaithilingaraja Arumugaswami; Sudhakar Sivasubramaniam
Journal:  Funct Integr Genomics       Date:  2022-04-13       Impact factor: 3.674

6.  ZBTB17 loss-of-function mutation contributes to familial dilated cardiomyopathy.

Authors:  Yu-Min Sun; Jun Wang; Ying-Jia Xu; Xin-Hua Wang; Fang Yuan; Hua Liu; Ruo-Gu Li; Min Zhang; Yan-Jie Li; Hong-Yu Shi; Liang Zhao; Xing-Biao Qiu; Xin-Kai Qu; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-02-14       Impact factor: 1.814

7.  Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.

Authors:  Yue Zhao; Hong Cao; Yindi Song; Yue Feng; Xiaoxue Ding; Mingjie Pang; Yunmei Zhang; Hong Zhang; Jiahuan Ding; Xueshan Xia
Journal:  Int J Mol Med       Date:  2016-04-14       Impact factor: 4.101

8.  GATA5 mutation homozygosity linked to a double outlet right ventricle phenotype in a Lebanese patient.

Authors:  Kameel Kassab; Hadla Hariri; Lara Gharibeh; Akl C Fahed; Manal Zein; Inaam El-Rassy; Mona Nemer; Issam El-Rassi; Fadi Bitar; Georges Nemer
Journal:  Mol Genet Genomic Med       Date:  2015-12-20       Impact factor: 2.183

9.  Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy.

Authors:  Yue Zhao; Yue Feng; Yun-Mei Zhang; Xiao-Xue Ding; Yu-Zhu Song; A-Mei Zhang; Li Liu; Hong Zhang; Jia-Huan Ding; Xue-Shan Xia
Journal:  Int J Mol Med       Date:  2015-10-07       Impact factor: 4.101

Review 10.  Genetics and genomics of dilated cardiomyopathy and systolic heart failure.

Authors:  Upasana Tayal; Sanjay Prasad; Stuart A Cook
Journal:  Genome Med       Date:  2017-02-22       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.